ClinicalTrials.Veeva

Menu

Efficacy of Melatonin in Burning Mouth Syndrome (BMS) (BMS2013)

U

University of Milan

Status

Completed

Conditions

Burning Mouth Syndrome

Treatments

Dietary Supplement: melatonin

Study type

Interventional

Funder types

Other

Identifiers

NCT02580734
BMS2013

Details and patient eligibility

About

The purpose of this study is to determine whether melatonin is effective in the treatment of burning mouth syndrome (BMS).

Full description

This is a crossover trial involving a total of 20 patients with Burning Mouth Syndrome, considered a chronic neuropathic pain. In two consecutive treatment periods, both 8 week long, each patient receives externally indistinguishable capsules (placebo or melatonin). A 4 weeks wash-out period is applied, between these two periods.

The capsules contain either placebo or 3 mg-melatonin (4 time/day for a total of 12 mg/day of melatonin). The primary endpoint is the change in pain intensity at the end of each treatment period, measured using VAS, verbal intensity score and NRS, as well as number of oral sites affected by the burning sensation. Furthermore, data from quality of life, anxiety and sleep questionnaires are collected (sf-36, HAM-A, ESS, MOS).

Adverse effects are carefully recorded as well as blood samples, in order to measure serum melatonin levels during the trial.

Enrollment

20 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients over 18 yrs suffering from burning mouth syndrome

Exclusion criteria

  • epilepsy
  • pregnancy
  • concomitant treatment with melatonin
  • concomitant anticoagulants
  • night time working persons

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups, including a placebo group

placebo
Placebo Comparator group
Description:
tablet without melatonin
Treatment:
Dietary Supplement: melatonin
melatonin
Experimental group
Description:
tablet with melatonin
Treatment:
Dietary Supplement: melatonin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems